TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Baggium Vård & Behandling AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
10,231
|
10,400
|
8,669 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-723
|
-242
|
-258 |
| EBITDA |
-569
|
-91
|
-131 |
| Total assets |
2,981
|
3,158
|
3,276 |
| Current assets |
1,912
|
2,065
|
1,786 |
| Current liabilities |
1,481
|
1,732
|
1,855 |
| Equity capital |
1,349
|
1,425
|
1,421 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
124
|
110
|
97 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
45.3%
|
45.1%
|
43.4% |
| Turnover per employee |
83
|
95
|
89 |
| Profit as a percentage of turnover |
-7.1%
|
-2.3%
|
-3.0% |
| Return on assets (ROA) |
-24.3%
|
-7.7%
|
-7.9% |
| Current ratio |
129.1%
|
119.2%
|
96.3% |
| Return on equity (ROE) |
-53.6%
|
-17.0%
|
-18.2% |
| Change turnover |
185
|
1,705
|
48 |
| Change turnover % |
2%
|
20%
|
1% |
| Chg. No. of employees |
14
|
13
|
-13 |
| Chg. No. of employees % |
13%
|
13%
|
-12% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.